Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Acq. announced
Quarterly results
Consulting agrmnt
CC transcript
|
|
LABORATORY CORP OF AMERICA HOLDINGS (LH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| ANDERSON KERRII B (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 5,000 shares
@ $211.5665, valued at
$1.1M
|
|
| 08/03/2023 |
4
| Wilkinson Peter J (SVP, Chief Accounting Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 17 shares
@ $213.61, valued at
$3.6k
Exercised 56 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 6,207 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Wilkinson Peter J (SVP, Chief Accounting Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,104 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Summy Amy B. (EVP, Chief Marketing Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 5,824 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Schroeder Mark S (EVP, Pres Diagnostics & COO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 11,648 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 73,013 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| EISENBERG GLENN A (CFO, EVP) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 20,193 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| DiVincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,036 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Caveney Brian J (EVP, Pres of ED, CMO & CSO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 11,648 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| BERBERIAN LANCE (EVP, CIO & CTO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 7,758 restricted stock units
@ $0 |
|
| 07/03/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 212 shares
@ $240, valued at
$50.9k
|
|
| 06/08/2023 |
4
| Rothman Paul (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 642 restricted stock units
@ $0 |
|
| 05/23/2023 |
4
| Kirchgraber Paul R (CEO, Covance Drug Development) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 4,300 shares
@ $216.9086, valued at
$932.7k
Exercised 4,300 options to buy
@ $182.51, valued at
$784.8k
|
|
| 05/09/2023 |
4
| Schroeder Mark S (EVP, Pres Diagnostics & COO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 1,400 options to buy
@ $223.86, valued at
$313.4k
Granted 440 restricted stock units
@ $0 |
|
| 05/09/2023 |
4
| Caveney Brian J (EVP, Pres of ED, CMO & CSO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 1,000 options to buy
@ $223.86, valued at
$223.9k
Granted 300 restricted stock units
@ $0 |
|
| 05/09/2023 |
4
| Bailey Megan D. (EVP, Chief Strategy Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 180 restricted stock units
@ $0
Granted 600 options to buy
@ $223.86, valued at
$134.3k
|
|
| 05/09/2023 |
4
| DiVincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 1,200 options to buy
@ $223.86, valued at
$268.6k
Granted 370 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 42,353 shares
@ $0
Paid exercise price by delivering 18,646 shares
@ $224.7, valued at
$4.2M
|
|
| 04/03/2023 |
4
| Kirchgraber Paul R (CEO, Covance Drug Development) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 6,763 shares
@ $0
Paid exercise price by delivering 2,886 shares
@ $224.7, valued at
$648.5k
|
|
| 04/03/2023 |
4
| EISENBERG GLENN A (CFO, EVP) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 11,715 shares
@ $0
Paid exercise price by delivering 5,179 shares
@ $224.7, valued at
$1.2M
|
|
| 04/03/2023 |
4
| Caveney Brian J (EVP, President of Diagnostics) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 6,763 shares
@ $0
Paid exercise price by delivering 2,990 shares
@ $224.7, valued at
$671.9k
|
|
| 04/03/2023 |
4
| BERBERIAN LANCE (EVP, CIO & CTO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 4,509 shares
@ $0
Paid exercise price by delivering 1,799 shares
@ $224.7, valued at
$404.2k
|
|
| 04/03/2023 |
4
| Schroeder Mark S (EVP, President-Diagnostics Lab) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 6,763 shares
@ $0
Paid exercise price by delivering 2,866 shares
@ $224.7, valued at
$644k
Sold 3,897 shares
@ $225.81, valued at
$880k
|
|
| 04/03/2023 |
4
| Seltz Judith C (EVP, CHRO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,381 shares
@ $0
Paid exercise price by delivering 1,164 shares
@ $224.7, valued at
$261.6k
|
|
| 04/03/2023 |
4
| Summy Amy B. (EVP, Chief Marketing Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,234 shares
@ $0
Paid exercise price by delivering 1,269 shares
@ $224.7, valued at
$285.1k
|
|
| 04/03/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,609 shares
@ $0
Paid exercise price by delivering 1,371 shares
@ $224.7, valued at
$308.1k
|
|
| 04/03/2023 |
4
| Wilkinson Peter J (SVP, Chief Accounting Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 1,798 shares
@ $0
Paid exercise price by delivering 526 shares
@ $224.7, valued at
$118.2k
|
|
| 03/06/2023 |
4
| Summy Amy B. (EVP, Chief Marketing Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 374 shares
@ $239.46, valued at
$89.6k
Exercised 1,340 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Kirchgraber Paul R (CEO, Covance Drug Development) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 8,000 shares
@ $250.5844, valued at
$2M
Exercised 3,000 options to buy
@ $182.51, valued at
$547.5k
|
|
| 02/14/2023 |
4
| BELINGARD JEAN-LUC (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 75 shares
@ $248.13, valued at
$18.6k
Exercised 742 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| ANDERSON KERRII B (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Exercised 742 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Davis Jeffrey A. (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Exercised 742 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Gilliland Dwight Gary (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Exercised 742 restricted stock units
@ $0 |
|
|
|
|